nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—Dry mouth—Docetaxel—ovarian cancer	0.000347	0.000393	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000347	0.000392	CcSEcCtD
Memantine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000346	0.000392	CcSEcCtD
Memantine—Fatigue—Paclitaxel—ovarian cancer	0.000346	0.000391	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—ovarian cancer	0.000345	0.00039	CcSEcCtD
Memantine—Pain—Paclitaxel—ovarian cancer	0.000343	0.000388	CcSEcCtD
Memantine—Constipation—Paclitaxel—ovarian cancer	0.000343	0.000388	CcSEcCtD
Memantine—Haematuria—Epirubicin—ovarian cancer	0.000343	0.000388	CcSEcCtD
Memantine—Confusional state—Docetaxel—ovarian cancer	0.000343	0.000388	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00034	0.000385	CcSEcCtD
Memantine—Oedema—Docetaxel—ovarian cancer	0.00034	0.000385	CcSEcCtD
Memantine—Weight increased—Doxorubicin—ovarian cancer	0.00034	0.000384	CcSEcCtD
Memantine—Epistaxis—Epirubicin—ovarian cancer	0.000339	0.000384	CcSEcCtD
Memantine—Infection—Docetaxel—ovarian cancer	0.000338	0.000382	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—ovarian cancer	0.000338	0.000382	CcSEcCtD
Memantine—Sinusitis—Epirubicin—ovarian cancer	0.000337	0.000382	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000337	0.000381	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—ovarian cancer	0.000336	0.00038	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—ovarian cancer	0.000335	0.000379	CcSEcCtD
Memantine—Shock—Docetaxel—ovarian cancer	0.000335	0.000379	CcSEcCtD
Memantine—Nervous system disorder—Docetaxel—ovarian cancer	0.000334	0.000377	CcSEcCtD
Memantine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000333	0.000377	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—ovarian cancer	0.000333	0.000376	CcSEcCtD
Memantine—Infestation—Doxorubicin—ovarian cancer	0.000333	0.000376	CcSEcCtD
Memantine—Tachycardia—Docetaxel—ovarian cancer	0.000332	0.000375	CcSEcCtD
Memantine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000331	0.000374	CcSEcCtD
Memantine—Skin disorder—Docetaxel—ovarian cancer	0.00033	0.000374	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00033	0.000373	CcSEcCtD
Memantine—Bradycardia—Epirubicin—ovarian cancer	0.000329	0.000372	CcSEcCtD
Memantine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000328	0.000371	CcSEcCtD
Memantine—Renal failure—Doxorubicin—ovarian cancer	0.000327	0.00037	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000326	0.000369	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—ovarian cancer	0.000325	0.000367	CcSEcCtD
Memantine—Anorexia—Docetaxel—ovarian cancer	0.000324	0.000367	CcSEcCtD
Memantine—Rhinitis—Epirubicin—ovarian cancer	0.000324	0.000366	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000324	0.000366	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000324	0.000366	CcSEcCtD
Memantine—Hepatitis—Epirubicin—ovarian cancer	0.000323	0.000365	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—ovarian cancer	0.000323	0.000365	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000321	0.000363	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—ovarian cancer	0.000321	0.000363	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000319	0.000361	CcSEcCtD
Memantine—Urticaria—Paclitaxel—ovarian cancer	0.000319	0.000361	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—ovarian cancer	0.000318	0.00036	CcSEcCtD
Memantine—Hypotension—Docetaxel—ovarian cancer	0.000318	0.00036	CcSEcCtD
Memantine—Haematuria—Doxorubicin—ovarian cancer	0.000317	0.000359	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000317	0.000359	CcSEcCtD
Memantine—Abdominal pain—Paclitaxel—ovarian cancer	0.000317	0.000359	CcSEcCtD
Memantine—Body temperature increased—Paclitaxel—ovarian cancer	0.000317	0.000359	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—ovarian cancer	0.000317	0.000358	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000315	0.000356	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—ovarian cancer	0.000314	0.000355	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—ovarian cancer	0.000312	0.000353	CcSEcCtD
Memantine—Visual impairment—Epirubicin—ovarian cancer	0.000311	0.000352	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000311	0.000351	CcSEcCtD
Memantine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00031	0.000351	CcSEcCtD
Memantine—Insomnia—Docetaxel—ovarian cancer	0.000308	0.000348	CcSEcCtD
Memantine—Paraesthesia—Docetaxel—ovarian cancer	0.000305	0.000345	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—ovarian cancer	0.000305	0.000345	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—ovarian cancer	0.000304	0.000344	CcSEcCtD
Memantine—Dyspnoea—Docetaxel—ovarian cancer	0.000303	0.000343	CcSEcCtD
Memantine—Somnolence—Docetaxel—ovarian cancer	0.000302	0.000342	CcSEcCtD
Memantine—Eye disorder—Epirubicin—ovarian cancer	0.000302	0.000341	CcSEcCtD
Memantine—Tinnitus—Epirubicin—ovarian cancer	0.000301	0.000341	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—ovarian cancer	0.0003	0.00034	CcSEcCtD
Memantine—Flushing—Epirubicin—ovarian cancer	0.0003	0.000339	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—ovarian cancer	0.0003	0.000339	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—ovarian cancer	0.0003	0.000339	CcSEcCtD
Memantine—Dyspepsia—Docetaxel—ovarian cancer	0.000299	0.000339	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—ovarian cancer	0.000299	0.000338	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—ovarian cancer	0.000299	0.000338	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000297	0.000336	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—ovarian cancer	0.000297	0.000335	CcSEcCtD
Memantine—Decreased appetite—Docetaxel—ovarian cancer	0.000296	0.000334	CcSEcCtD
Memantine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000296	0.000334	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000295	0.000334	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000294	0.000333	CcSEcCtD
Memantine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000294	0.000332	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000294	0.000332	CcSEcCtD
Memantine—Fatigue—Docetaxel—ovarian cancer	0.000293	0.000332	CcSEcCtD
Memantine—Angiopathy—Epirubicin—ovarian cancer	0.000293	0.000331	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—ovarian cancer	0.000293	0.000331	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—ovarian cancer	0.000292	0.00033	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000291	0.000329	CcSEcCtD
Memantine—Pain—Docetaxel—ovarian cancer	0.000291	0.000329	CcSEcCtD
Memantine—Constipation—Docetaxel—ovarian cancer	0.000291	0.000329	CcSEcCtD
Memantine—Chills—Epirubicin—ovarian cancer	0.00029	0.000328	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—ovarian cancer	0.000288	0.000326	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—ovarian cancer	0.000288	0.000326	CcSEcCtD
Memantine—Asthenia—Paclitaxel—ovarian cancer	0.000288	0.000326	CcSEcCtD
Memantine—Alopecia—Epirubicin—ovarian cancer	0.000285	0.000323	CcSEcCtD
Memantine—Pruritus—Paclitaxel—ovarian cancer	0.000284	0.000321	CcSEcCtD
Memantine—Mental disorder—Epirubicin—ovarian cancer	0.000283	0.00032	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000283	0.00032	CcSEcCtD
Memantine—Malnutrition—Epirubicin—ovarian cancer	0.000281	0.000318	CcSEcCtD
Memantine—Feeling abnormal—Docetaxel—ovarian cancer	0.00028	0.000317	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—ovarian cancer	0.000279	0.000316	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—ovarian cancer	0.000279	0.000315	CcSEcCtD
Memantine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000278	0.000315	CcSEcCtD
Memantine—Flushing—Doxorubicin—ovarian cancer	0.000277	0.000314	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000277	0.000314	CcSEcCtD
Memantine—Flatulence—Epirubicin—ovarian cancer	0.000277	0.000313	CcSEcCtD
Memantine—Tension—Epirubicin—ovarian cancer	0.000276	0.000312	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—ovarian cancer	0.000275	0.000311	CcSEcCtD
Memantine—Diarrhoea—Paclitaxel—ovarian cancer	0.000275	0.000311	CcSEcCtD
Memantine—Nervousness—Epirubicin—ovarian cancer	0.000273	0.000309	CcSEcCtD
Memantine—Back pain—Epirubicin—ovarian cancer	0.000272	0.000308	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—ovarian cancer	0.000271	0.000307	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—ovarian cancer	0.00027	0.000305	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000269	0.000305	CcSEcCtD
Memantine—Abdominal pain—Docetaxel—ovarian cancer	0.000269	0.000304	CcSEcCtD
Memantine—Body temperature increased—Docetaxel—ovarian cancer	0.000269	0.000304	CcSEcCtD
Memantine—Chills—Doxorubicin—ovarian cancer	0.000268	0.000303	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—ovarian cancer	0.000267	0.000302	CcSEcCtD
Memantine—Dizziness—Paclitaxel—ovarian cancer	0.000265	0.0003	CcSEcCtD
Memantine—Vision blurred—Epirubicin—ovarian cancer	0.000265	0.0003	CcSEcCtD
Memantine—Alopecia—Doxorubicin—ovarian cancer	0.000264	0.000299	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—ovarian cancer	0.000262	0.000296	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000261	0.000295	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—ovarian cancer	0.00026	0.000294	CcSEcCtD
Memantine—Anaemia—Epirubicin—ovarian cancer	0.00026	0.000294	CcSEcCtD
Memantine—Agitation—Epirubicin—ovarian cancer	0.000258	0.000292	CcSEcCtD
Memantine—Flatulence—Doxorubicin—ovarian cancer	0.000256	0.00029	CcSEcCtD
Memantine—Tension—Doxorubicin—ovarian cancer	0.000255	0.000289	CcSEcCtD
Memantine—Vomiting—Paclitaxel—ovarian cancer	0.000255	0.000289	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—ovarian cancer	0.000255	0.000288	CcSEcCtD
Memantine—Malaise—Epirubicin—ovarian cancer	0.000254	0.000287	CcSEcCtD
Memantine—Rash—Paclitaxel—ovarian cancer	0.000253	0.000286	CcSEcCtD
Memantine—Dermatitis—Paclitaxel—ovarian cancer	0.000253	0.000286	CcSEcCtD
Memantine—Nervousness—Doxorubicin—ovarian cancer	0.000253	0.000286	CcSEcCtD
Memantine—Vertigo—Epirubicin—ovarian cancer	0.000253	0.000286	CcSEcCtD
Memantine—Syncope—Epirubicin—ovarian cancer	0.000252	0.000285	CcSEcCtD
Memantine—Leukopenia—Epirubicin—ovarian cancer	0.000252	0.000285	CcSEcCtD
Memantine—Back pain—Doxorubicin—ovarian cancer	0.000252	0.000285	CcSEcCtD
Memantine—Headache—Paclitaxel—ovarian cancer	0.000251	0.000284	CcSEcCtD
Memantine—Hypersensitivity—Docetaxel—ovarian cancer	0.000251	0.000283	CcSEcCtD
Memantine—Palpitations—Epirubicin—ovarian cancer	0.000248	0.000281	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—ovarian cancer	0.000247	0.000279	CcSEcCtD
Memantine—Cough—Epirubicin—ovarian cancer	0.000245	0.000277	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—ovarian cancer	0.000245	0.000277	CcSEcCtD
Memantine—Asthenia—Docetaxel—ovarian cancer	0.000244	0.000276	CcSEcCtD
Memantine—Convulsion—Epirubicin—ovarian cancer	0.000244	0.000275	CcSEcCtD
Memantine—Hypertension—Epirubicin—ovarian cancer	0.000243	0.000275	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000241	0.000273	CcSEcCtD
Memantine—Pruritus—Docetaxel—ovarian cancer	0.000241	0.000272	CcSEcCtD
Memantine—Anaemia—Doxorubicin—ovarian cancer	0.00024	0.000272	CcSEcCtD
Memantine—Chest pain—Epirubicin—ovarian cancer	0.000239	0.000271	CcSEcCtD
Memantine—Arthralgia—Epirubicin—ovarian cancer	0.000239	0.000271	CcSEcCtD
Memantine—Myalgia—Epirubicin—ovarian cancer	0.000239	0.000271	CcSEcCtD
Memantine—Agitation—Doxorubicin—ovarian cancer	0.000239	0.00027	CcSEcCtD
Memantine—Anxiety—Epirubicin—ovarian cancer	0.000239	0.00027	CcSEcCtD
Memantine—Nausea—Paclitaxel—ovarian cancer	0.000238	0.00027	CcSEcCtD
Memantine—Discomfort—Epirubicin—ovarian cancer	0.000236	0.000267	CcSEcCtD
Memantine—Malaise—Doxorubicin—ovarian cancer	0.000235	0.000265	CcSEcCtD
Memantine—Dry mouth—Epirubicin—ovarian cancer	0.000234	0.000265	CcSEcCtD
Memantine—Vertigo—Doxorubicin—ovarian cancer	0.000234	0.000264	CcSEcCtD
Memantine—Syncope—Doxorubicin—ovarian cancer	0.000233	0.000264	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—ovarian cancer	0.000233	0.000263	CcSEcCtD
Memantine—Diarrhoea—Docetaxel—ovarian cancer	0.000233	0.000263	CcSEcCtD
Memantine—Confusional state—Epirubicin—ovarian cancer	0.000231	0.000262	CcSEcCtD
Memantine—Palpitations—Doxorubicin—ovarian cancer	0.00023	0.00026	CcSEcCtD
Memantine—Oedema—Epirubicin—ovarian cancer	0.000229	0.00026	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000229	0.000259	CcSEcCtD
Memantine—Infection—Epirubicin—ovarian cancer	0.000228	0.000258	CcSEcCtD
Memantine—Cough—Doxorubicin—ovarian cancer	0.000227	0.000257	CcSEcCtD
Memantine—Shock—Epirubicin—ovarian cancer	0.000226	0.000255	CcSEcCtD
Memantine—Convulsion—Doxorubicin—ovarian cancer	0.000225	0.000255	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—ovarian cancer	0.000225	0.000254	CcSEcCtD
Memantine—Dizziness—Docetaxel—ovarian cancer	0.000225	0.000254	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000225	0.000254	CcSEcCtD
Memantine—Hypertension—Doxorubicin—ovarian cancer	0.000225	0.000254	CcSEcCtD
Memantine—Tachycardia—Epirubicin—ovarian cancer	0.000224	0.000253	CcSEcCtD
Memantine—Skin disorder—Epirubicin—ovarian cancer	0.000223	0.000252	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000222	0.000251	CcSEcCtD
Memantine—Myalgia—Doxorubicin—ovarian cancer	0.000221	0.00025	CcSEcCtD
Memantine—Chest pain—Doxorubicin—ovarian cancer	0.000221	0.00025	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—ovarian cancer	0.000221	0.00025	CcSEcCtD
Memantine—Anxiety—Doxorubicin—ovarian cancer	0.000221	0.00025	CcSEcCtD
Memantine—Discomfort—Doxorubicin—ovarian cancer	0.000219	0.000247	CcSEcCtD
Memantine—Anorexia—Epirubicin—ovarian cancer	0.000219	0.000247	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—ovarian cancer	0.000217	0.000245	CcSEcCtD
Memantine—Vomiting—Docetaxel—ovarian cancer	0.000216	0.000245	CcSEcCtD
Memantine—Rash—Docetaxel—ovarian cancer	0.000214	0.000243	CcSEcCtD
Memantine—Hypotension—Epirubicin—ovarian cancer	0.000214	0.000242	CcSEcCtD
Memantine—Dermatitis—Docetaxel—ovarian cancer	0.000214	0.000242	CcSEcCtD
Memantine—Confusional state—Doxorubicin—ovarian cancer	0.000214	0.000242	CcSEcCtD
Memantine—Headache—Docetaxel—ovarian cancer	0.000213	0.000241	CcSEcCtD
Memantine—Oedema—Doxorubicin—ovarian cancer	0.000212	0.00024	CcSEcCtD
Memantine—Infection—Doxorubicin—ovarian cancer	0.000211	0.000239	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000209	0.000236	CcSEcCtD
Memantine—Shock—Doxorubicin—ovarian cancer	0.000209	0.000236	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000208	0.000235	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000208	0.000235	CcSEcCtD
Memantine—Insomnia—Epirubicin—ovarian cancer	0.000208	0.000235	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—ovarian cancer	0.000207	0.000234	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—ovarian cancer	0.000206	0.000233	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—ovarian cancer	0.000206	0.000233	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000205	0.000232	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—ovarian cancer	0.000205	0.000231	CcSEcCtD
Memantine—Somnolence—Epirubicin—ovarian cancer	0.000204	0.000231	CcSEcCtD
Memantine—GRIN2B—Axon guidance—IL6ST—ovarian cancer	0.000203	0.00175	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—ovarian cancer	0.000203	0.00175	CbGpPWpGaD
Memantine—Anorexia—Doxorubicin—ovarian cancer	0.000202	0.000229	CcSEcCtD
Memantine—Nausea—Docetaxel—ovarian cancer	0.000202	0.000229	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—ovarian cancer	0.000202	0.000228	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000202	0.00174	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—MAPK1—ovarian cancer	0.000201	0.00173	CbGpPWpGaD
Memantine—Decreased appetite—Epirubicin—ovarian cancer	0.000199	0.000226	CcSEcCtD
Memantine—Hypotension—Doxorubicin—ovarian cancer	0.000198	0.000224	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000198	0.000224	CcSEcCtD
Memantine—Fatigue—Epirubicin—ovarian cancer	0.000198	0.000224	CcSEcCtD
Memantine—Pain—Epirubicin—ovarian cancer	0.000196	0.000222	CcSEcCtD
Memantine—Constipation—Epirubicin—ovarian cancer	0.000196	0.000222	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000194	0.00167	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000193	0.000219	CcSEcCtD
Memantine—Insomnia—Doxorubicin—ovarian cancer	0.000192	0.000217	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—ovarian cancer	0.000191	0.000216	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—ovarian cancer	0.000189	0.000214	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—ovarian cancer	0.000189	0.000214	CcSEcCtD
Memantine—Somnolence—Doxorubicin—ovarian cancer	0.000189	0.000213	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000188	0.000212	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—ovarian cancer	0.000187	0.000211	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—IL6—ovarian cancer	0.000185	0.0016	CbGpPWpGaD
Memantine—Decreased appetite—Doxorubicin—ovarian cancer	0.000185	0.000209	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000183	0.000207	CcSEcCtD
Memantine—Fatigue—Doxorubicin—ovarian cancer	0.000183	0.000207	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—TYMS—ovarian cancer	0.000183	0.00158	CbGpPWpGaD
Memantine—Urticaria—Epirubicin—ovarian cancer	0.000182	0.000206	CcSEcCtD
Memantine—Pain—Doxorubicin—ovarian cancer	0.000182	0.000205	CcSEcCtD
Memantine—Constipation—Doxorubicin—ovarian cancer	0.000182	0.000205	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—ovarian cancer	0.000181	0.000205	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—ovarian cancer	0.000181	0.000205	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000181	0.00157	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000178	0.00154	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NME2—ovarian cancer	0.000177	0.00153	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MMP2—ovarian cancer	0.000177	0.00153	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000175	0.000198	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000174	0.000196	CcSEcCtD
Memantine—GRIN2B—Axon guidance—MMP2—ovarian cancer	0.000173	0.00149	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000172	0.00148	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—ovarian cancer	0.000169	0.000191	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000169	0.00146	CbGpPWpGaD
Memantine—Urticaria—Doxorubicin—ovarian cancer	0.000169	0.000191	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—ovarian cancer	0.000168	0.00019	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—ovarian cancer	0.000168	0.00019	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—HRAS—ovarian cancer	0.000165	0.00143	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000165	0.00142	CbGpPWpGaD
Memantine—Asthenia—Epirubicin—ovarian cancer	0.000165	0.000186	CcSEcCtD
Memantine—CYP2A6—Metabolism—NME2—ovarian cancer	0.000163	0.0014	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000163	0.0014	CbGpPWpGaD
Memantine—Pruritus—Epirubicin—ovarian cancer	0.000162	0.000184	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—ovarian cancer	0.000161	0.00139	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00016	0.00138	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000158	0.00137	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—ovarian cancer	0.000157	0.000178	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000156	0.000177	CcSEcCtD
Memantine—GRIN1—Axon guidance—ERBB2—ovarian cancer	0.000155	0.00134	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000154	0.00133	CbGpPWpGaD
Memantine—Asthenia—Doxorubicin—ovarian cancer	0.000152	0.000172	CcSEcCtD
Memantine—Dizziness—Epirubicin—ovarian cancer	0.000152	0.000172	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MET—ovarian cancer	0.000151	0.00131	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—ERBB2—ovarian cancer	0.000151	0.0013	CbGpPWpGaD
Memantine—Pruritus—Doxorubicin—ovarian cancer	0.00015	0.00017	CcSEcCtD
Memantine—GRIN1—Developmental Biology—IL6ST—ovarian cancer	0.000148	0.00128	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000148	0.00128	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MET—ovarian cancer	0.000148	0.00127	CbGpPWpGaD
Memantine—Vomiting—Epirubicin—ovarian cancer	0.000146	0.000165	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—AKT1—ovarian cancer	0.000146	0.00126	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000146	0.00126	CbGpPWpGaD
Memantine—Diarrhoea—Doxorubicin—ovarian cancer	0.000145	0.000164	CcSEcCtD
Memantine—Rash—Epirubicin—ovarian cancer	0.000145	0.000164	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—IL6ST—ovarian cancer	0.000145	0.00125	CbGpPWpGaD
Memantine—Dermatitis—Epirubicin—ovarian cancer	0.000145	0.000163	CcSEcCtD
Memantine—Headache—Epirubicin—ovarian cancer	0.000144	0.000163	CcSEcCtD
Memantine—DRD2—Signaling Pathways—HSD17B6—ovarian cancer	0.000143	0.00123	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—ovarian cancer	0.000142	0.00123	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—ovarian cancer	0.00014	0.000159	CcSEcCtD
Memantine—GRIN2A—Neuronal System—MAPK1—ovarian cancer	0.000139	0.0012	CbGpPWpGaD
Memantine—Nausea—Epirubicin—ovarian cancer	0.000136	0.000154	CcSEcCtD
Memantine—Vomiting—Doxorubicin—ovarian cancer	0.000135	0.000153	CcSEcCtD
Memantine—Rash—Doxorubicin—ovarian cancer	0.000134	0.000151	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—ovarian cancer	0.000134	0.000151	CcSEcCtD
Memantine—GRIN1—Axon guidance—MMP9—ovarian cancer	0.000133	0.00115	CbGpPWpGaD
Memantine—Headache—Doxorubicin—ovarian cancer	0.000133	0.00015	CcSEcCtD
Memantine—CYP2B6—Metabolism—NME2—ovarian cancer	0.000131	0.00113	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—ovarian cancer	0.00013	0.00112	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000127	0.0011	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP2—ovarian cancer	0.000126	0.00109	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—ovarian cancer	0.000126	0.000143	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000125	0.00108	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000124	0.00107	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP2—ovarian cancer	0.000123	0.00106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DLC1—ovarian cancer	0.000121	0.00105	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—MAPK1—ovarian cancer	0.000121	0.00105	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—ovarian cancer	0.000119	0.00103	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—MAPK1—ovarian cancer	0.000118	0.00102	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—ovarian cancer	0.000118	0.00102	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—ovarian cancer	0.000116	0.00101	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NRAS—ovarian cancer	0.000115	0.000993	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000115	0.000988	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYTB—ovarian cancer	0.000114	0.000984	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK3—ovarian cancer	0.000113	0.000975	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—ovarian cancer	0.000112	0.000963	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—ovarian cancer	0.000111	0.000955	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000111	0.000954	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MAPK3—ovarian cancer	0.00011	0.000951	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—ovarian cancer	0.000108	0.000931	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK1—ovarian cancer	0.000108	0.000928	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—ovarian cancer	0.000108	0.000928	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MAPK1—ovarian cancer	0.000105	0.000905	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—ovarian cancer	0.000105	0.000904	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYTB—ovarian cancer	0.000105	0.000904	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—ovarian cancer	0.000102	0.000877	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPP1CC—ovarian cancer	9.97e-05	0.000861	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BRIP1—ovarian cancer	9.97e-05	0.000861	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NME2—ovarian cancer	9.91e-05	0.000855	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—ovarian cancer	9.9e-05	0.000854	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BCL9—ovarian cancer	9.9e-05	0.000854	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—ovarian cancer	9.73e-05	0.00084	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—ovarian cancer	9.68e-05	0.000836	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—ovarian cancer	9.49e-05	0.000819	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—ovarian cancer	9.49e-05	0.000819	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—ovarian cancer	9.44e-05	0.000815	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—ovarian cancer	9.26e-05	0.000799	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPP1CC—ovarian cancer	9.15e-05	0.00079	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BRIP1—ovarian cancer	9.15e-05	0.00079	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—ovarian cancer	8.89e-05	0.000767	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.73e-05	0.000753	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—ovarian cancer	8.73e-05	0.000753	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—ovarian cancer	8.63e-05	0.000745	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—ovarian cancer	8.53e-05	0.000736	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYTB—ovarian cancer	8.45e-05	0.000729	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—ovarian cancer	8.44e-05	0.000728	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—ovarian cancer	8.42e-05	0.000727	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—ovarian cancer	8.42e-05	0.000726	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.41e-05	0.000725	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—ovarian cancer	8.31e-05	0.000717	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—ovarian cancer	8.26e-05	0.000713	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—ovarian cancer	8.23e-05	0.00071	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.22e-05	0.00071	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—ovarian cancer	8.21e-05	0.000708	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MAPK3—ovarian cancer	8.07e-05	0.000696	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—ovarian cancer	8.06e-05	0.000695	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK3—ovarian cancer	7.86e-05	0.000678	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DOK1—ovarian cancer	7.83e-05	0.000675	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MAPK1—ovarian cancer	7.67e-05	0.000662	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—ovarian cancer	7.67e-05	0.000662	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK1—ovarian cancer	7.48e-05	0.000646	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—ovarian cancer	7.48e-05	0.000645	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BRIP1—ovarian cancer	7.39e-05	0.000637	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	7.39e-05	0.000637	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP1CC—ovarian cancer	7.36e-05	0.000635	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—ovarian cancer	7.25e-05	0.000625	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—ovarian cancer	7.07e-05	0.00061	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	6.94e-05	0.000599	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.85e-05	0.000591	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—YAP1—ovarian cancer	6.69e-05	0.000577	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.6e-05	0.00057	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYTB—ovarian cancer	6.39e-05	0.000551	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	6.3e-05	0.000544	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.24e-05	0.000539	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—ovarian cancer	6.16e-05	0.000532	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—YAP1—ovarian cancer	6.14e-05	0.00053	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—ovarian cancer	6.07e-05	0.000524	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—ovarian cancer	6.01e-05	0.000518	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—ovarian cancer	5.9e-05	0.000509	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—ovarian cancer	5.75e-05	0.000496	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BRIP1—ovarian cancer	5.58e-05	0.000482	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	5.58e-05	0.000482	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC6—ovarian cancer	5.58e-05	0.000481	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—ovarian cancer	5.55e-05	0.000479	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PPP2R1A—ovarian cancer	5.5e-05	0.000475	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—FASN—ovarian cancer	5.45e-05	0.00047	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—ovarian cancer	5.44e-05	0.000469	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	5.36e-05	0.000463	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—ovarian cancer	5.3e-05	0.000458	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—ovarian cancer	5.28e-05	0.000456	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	5.18e-05	0.000447	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—ovarian cancer	5.06e-05	0.000437	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FASN—ovarian cancer	5.01e-05	0.000432	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	4.97e-05	0.000429	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—YAP1—ovarian cancer	4.95e-05	0.000427	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—YAP1—ovarian cancer	4.94e-05	0.000426	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—ovarian cancer	4.92e-05	0.000425	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—XIAP—ovarian cancer	4.84e-05	0.000417	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A1—ovarian cancer	4.75e-05	0.00041	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMARCA4—ovarian cancer	4.71e-05	0.000407	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EREG—ovarian cancer	4.6e-05	0.000397	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1B1—ovarian cancer	4.56e-05	0.000393	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	4.4e-05	0.00038	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PGR—ovarian cancer	4.31e-05	0.000372	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—ovarian cancer	4.09e-05	0.000353	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.07e-05	0.000351	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—ovarian cancer	4.06e-05	0.00035	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	4.04e-05	0.000349	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FASN—ovarian cancer	4.04e-05	0.000348	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—ovarian cancer	4.02e-05	0.000347	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PARP1—ovarian cancer	4.01e-05	0.000346	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	3.97e-05	0.000343	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	3.84e-05	0.000331	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6ST—ovarian cancer	3.83e-05	0.000331	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—ovarian cancer	3.75e-05	0.000324	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—YAP1—ovarian cancer	3.74e-05	0.000323	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.7e-05	0.00032	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—ovarian cancer	3.69e-05	0.000318	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—ovarian cancer	3.68e-05	0.000318	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.68e-05	0.000317	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—ovarian cancer	3.56e-05	0.000308	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	3.26e-05	0.000281	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.26e-05	0.000281	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP2R1A—ovarian cancer	3.25e-05	0.00028	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—ovarian cancer	3.24e-05	0.000279	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAV1—ovarian cancer	3.24e-05	0.000279	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—ovarian cancer	3.11e-05	0.000268	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FASN—ovarian cancer	3.05e-05	0.000263	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—ovarian cancer	3.03e-05	0.000261	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3e-05	0.000259	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—ovarian cancer	2.99e-05	0.000258	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—ovarian cancer	2.97e-05	0.000257	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAV1—ovarian cancer	2.97e-05	0.000256	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	2.95e-05	0.000254	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.9e-05	0.00025	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—ovarian cancer	2.85e-05	0.000246	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.84e-05	0.000245	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—ovarian cancer	2.82e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.78e-05	0.00024	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—ovarian cancer	2.71e-05	0.000234	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.71e-05	0.000234	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	2.59e-05	0.000224	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—ovarian cancer	2.59e-05	0.000224	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—ovarian cancer	2.58e-05	0.000223	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.47e-05	0.000213	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.45e-05	0.000212	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAV1—ovarian cancer	2.4e-05	0.000207	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CAV1—ovarian cancer	2.39e-05	0.000206	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2.38e-05	0.000205	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—ovarian cancer	2.3e-05	0.000199	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.29e-05	0.000198	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6ST—ovarian cancer	2.26e-05	0.000195	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	2.26e-05	0.000195	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—ovarian cancer	2.25e-05	0.000194	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	2.18e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—ovarian cancer	2.18e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—ovarian cancer	2.18e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—ovarian cancer	2.18e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—ovarian cancer	2.08e-05	0.00018	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.07e-05	0.000179	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK1—ovarian cancer	1.98e-05	0.000171	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—ovarian cancer	1.98e-05	0.000171	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—ovarian cancer	1.95e-05	0.000168	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.92e-05	0.000166	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—ovarian cancer	1.91e-05	0.000165	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—ovarian cancer	1.89e-05	0.000163	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—ovarian cancer	1.87e-05	0.000162	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAV1—ovarian cancer	1.81e-05	0.000156	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—ovarian cancer	1.79e-05	0.000155	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.73e-05	0.000149	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	1.72e-05	0.000148	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—ovarian cancer	1.69e-05	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.67e-05	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MTOR—ovarian cancer	1.67e-05	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	1.67e-05	0.000144	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.65e-05	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—ovarian cancer	1.6e-05	0.000138	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—ovarian cancer	1.59e-05	0.000137	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	1.56e-05	0.000135	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	1.55e-05	0.000134	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—ovarian cancer	1.53e-05	0.000132	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—ovarian cancer	1.53e-05	0.000132	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—ovarian cancer	1.52e-05	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—ovarian cancer	1.49e-05	0.000129	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	1.48e-05	0.000128	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.45e-05	0.000125	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—ovarian cancer	1.45e-05	0.000125	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—ovarian cancer	1.45e-05	0.000125	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—ovarian cancer	1.44e-05	0.000124	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	1.41e-05	0.000121	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	1.38e-05	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	1.3e-05	0.000112	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—ovarian cancer	1.29e-05	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—ovarian cancer	1.29e-05	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.26e-05	0.000109	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.26e-05	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	1.23e-05	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—ovarian cancer	1.2e-05	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	1.17e-05	0.000101	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—ovarian cancer	1.17e-05	0.000101	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—ovarian cancer	1.12e-05	9.71e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—ovarian cancer	1.11e-05	9.54e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—ovarian cancer	1.09e-05	9.43e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—ovarian cancer	1.03e-05	8.91e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.02e-05	8.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	1.02e-05	8.77e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—ovarian cancer	9.83e-06	8.48e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—ovarian cancer	9.4e-06	8.11e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—ovarian cancer	9e-06	7.76e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—ovarian cancer	8.33e-06	7.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—ovarian cancer	8.3e-06	7.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	7.71e-06	6.65e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—ovarian cancer	6.3e-06	5.43e-05	CbGpPWpGaD
